シンバイオ製薬（4582）の空売り残高
シンバイオ製薬（4582）の現在の空売り残高は 4,593,215株、対発行株数の割合は 5.98% です（2026-07-10公表時点、5機関が報告）。機関ごとの内訳を積み上げグラフで表示し、日次の合計残高（繰越反映）の推移もチャートで確認できます。
空売り残高（合計）の推移
- モルガン・スタンレーMUFG証券
- Barclays Capital Securities
- JPM Securities Japan Co
- GOLDMAN SACHS
- Nomura
- UBS
- Macquarie Bank
- Citigroup Global Markets
- MERRILL LYNCH
- JANE STREET GLOBAL TRADING
空売り者ごとの積み上げ（直近半年）。下の表は合計を最大12ヶ月分の数値で掲載。
繰越を反映した営業日ごとの空売り残高 合計（新しい順・直近90日を表示）。
| 計算日 | 残高数量（合計） | 残高割合 |
|---|---|---|
| 2026/04/13 | 3,410,401 | 4.73% (+0.45%) |
| 2026/04/10 | 3,085,581 | 4.28% (-0.41%) |
| 2026/04/09 | 3,391,140 | 4.69% (-0.61%) |
| 2026/04/08 | 3,829,640 | 5.30% (-0.61%) |
| 2026/04/07 | 4,264,365 | 5.91% (0.00%) |
| 2026/04/06 | 4,264,365 | 5.91% (-0.27%) |
| 2026/04/03 | 4,462,603 | 6.18% (0.00%) |
| 2026/04/02 | 4,462,603 | 6.18% (-0.18%) |
| 2026/04/01 | 4,587,480 | 6.36% (-0.04%) |
| 2026/03/31 | 4,615,476 | 6.40% (-0.70%) |
| 2026/03/30 | 5,123,276 | 7.10% (-0.66%) |
| 2026/03/27 | 5,605,710 | 7.76% (-0.52%) |
| 2026/03/26 | 5,976,958 | 8.28% (+0.04%) |
| 2026/03/25 | 5,946,458 | 8.24% (-1.09%) |
| 2026/03/24 | 6,700,328 | 9.33% (-0.49%) |
| 2026/03/23 | 7,055,415 | 9.82% (-0.75%) |
| 2026/03/19 | 7,853,179 | 11.04% (-1.02%) |
| 2026/03/18 | 8,278,249 | 12.06% (-0.31%) |
| 2026/03/17 | 8,491,255 | 12.37% (+0.61%) |
| 2026/03/16 | 8,055,626 | 11.76% (+5.51%) |
| 2026/03/13 | 4,302,621 | 6.25% (-0.07%) |
| 2026/03/12 | 4,347,591 | 6.32% (+0.42%) |
| 2026/03/11 | 4,053,080 | 5.90% (+0.41%) |
| 2026/03/10 | 3,767,723 | 5.49% (+0.34%) |
| 2026/03/09 | 3,536,835 | 5.15% (+0.17%) |
| 2026/03/06 | 3,407,807 | 4.98% (+0.63%) |
| 2026/03/05 | 2,966,882 | 4.35% (+0.14%) |
| 2026/03/04 | 2,874,782 | 4.21% (-1.08%) |
| 2026/03/03 | 3,624,339 | 5.29% (-1.69%) |
| 2026/03/02 | 4,771,432 | 6.98% (+0.32%) |
機関別の空売り残高（過去12ヶ月の報告）
直近12ヶ月の機関別 空売り残高の報告（計算日の新しい順、全547件中 直近90件を表示）。
| 空売り者 | 計算日 | 残高数量 | 残高割合 |
|---|---|---|---|
| Barclays Capital Securities | 6/2 | 895,325 | 1.17% (-0.09%) |
| Barclays Capital Securities | 6/1 | 957,325 | 1.26% (+0.13%) |
| Barclays Capital Securities | 5/29 | 853,725 | 1.13% (+0.17%) |
| Barclays Capital Securities | 5/28 | 729,025 | 0.96% (-0.14%) |
| JPM Securities Japan Co | 5/28 | 486,551 | 0.64% (+0.14%) |
| Barclays Capital Securities | 5/25 | 831,525 | 1.10% (+0.08%) |
| Barclays Capital Securities | 5/22 | 774,625 | 1.02% (+0.04%) |
| Barclays Capital Securities | 5/21 | 743,125 | 0.98% (-0.11%) |
| JPM Securities Japan Co | 5/21 | 378,451 | 0.50% (+0.01%) |
| JPM Securities Japan Co | 5/20 | 373,251 | 0.49% (-0.10%) |
| Barclays Capital Securities | 5/19 | 823,325 | 1.09% (-0.18%) |
| Barclays Capital Securities | 5/18 | 963,725 | 1.27% (-0.12%) |
| Barclays Capital Securities | 5/15 | 1,052,625 | 1.39% (-0.07%) |
| UBS | 5/14 | 354,300 | 0.46% (-0.04%) |
| Barclays Capital Securities | 5/12 | 1,102,225 | 1.46% (+0.13%) |
| UBS | 5/12 | 380,500 | 0.50% (+0.01%) |
| Barclays Capital Securities | 5/8 | 1,010,225 | 1.33% (-0.13%) |
| Barclays Capital Securities | 5/7 | 1,107,025 | 1.46% (-0.11%) |
| UBS | 5/7 | 371,100 | 0.49% (-0.04%) |
| JPM Securities Japan Co | 5/1 | 450,051 | 0.59% (-0.10%) |
| Barclays Capital Securities | 4/28 | 1,172,325 | 1.57% (-0.06%) |
| Barclays Capital Securities | 4/27 | 1,218,625 | 1.63% (+0.06%) |
| JPM Securities Japan Co | 4/27 | 515,051 | 0.69% (-0.10%) |
| GOLDMAN SACHS | 4/24 | 815,204 | 1.09% (-0.07%) |
| Barclays Capital Securities | 4/23 | 1,168,325 | 1.57% (+0.14%) |
| GOLDMAN SACHS | 4/23 | 866,804 | 1.16% (-0.11%) |
| UBS | 4/23 | 395,300 | 0.53% (+0.05%) |
| Barclays Capital Securities | 4/22 | 1,066,025 | 1.43% (+0.08%) |
| Barclays Capital Securities | 4/21 | 982,325 | 1.35% (+0.20%) |
| Barclays Capital Securities | 4/20 | 836,325 | 1.15% (-0.15%) |